Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 25
Directory
Microsites
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 25
Directory
Microsites
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
DCAT Week ’19
Temperature-Controlled Logistics
Reducing Pill Burden
Nasal Drug Delivery
AI in Pharma: Transforming Data into Drugs
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
SK, Arvelle Sign $530M Deal for Antiepileptic Drug
GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers
Progenics Launches Mfg. Ops in NJ
Charles River to Pay $510M for Citoxlab
West, Swissfillon Enter Drug Delivery Partnership
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
Progenics Launches Mfg. Ops in NJ
Pelican BioThermal Opens New Network Location
Reed-Lane Facility Tour
Haselmeier Acquires Drug Manufacturing License
Emerald Health, Lonza Enter Large-Scale Mfg. Pact
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers
Pelican BioThermal Opens New Network Location
Reed-Lane Facility Tour
Recipharm Facilities Ready for EU Serialization
Andrew Alliance, Sartorius Launch Research Solution
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Personalized Medicine: Getting More Out of Clinical Trials
SK, Arvelle Sign $530M Deal for Antiepileptic Drug
Charles River to Pay $510M for Citoxlab
West, Swissfillon Enter Drug Delivery Partnership
Jubilant Biosys, Sanofi Expand Collaboration
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Former FDA Senior Executives Join PAREXEL
Top Global Pharma Company to Implement ValGenesis' VLMS
WCG, Prudentia Enter Pharmacovigilance Alliance
ValGenesis VLMS Chosen to Digitize Validation Process
Serialization Compliance: Understanding the Challenges
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
Jubilant HollisterStier Contract Manufacturing & Services
Reed-Lane, Inc.
Ascendia Pharmaceuticals
Aphena Pharma Solutions, Inc.
Emergent BioSolutions, Inc.
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
Ascendia Pharmaceuticals
Baxter BioPharma Solutions
Jubilant HollisterStier Contract Manufacturing & Services
Alcami
Ajinomoto Bio-Pharma Services
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 25 Pharma & BioPharma
Top 20 Pharma & BioPharma
Top 10 BioPharma Companies
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Infographics
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Agenda
Conference Sessions
Supplier Microsite
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Search Results for '
immunotherapy
'
Search For:
Refine by Dates:
From:
To:
Past 7 Days
|
Past 30 Days
Refine By Content:
All
Advanced Degrees
Ask The Board
Ask The Experts
Back Page
Bio News & Views
Blog
Breaking News
Business Corner
Buyers Guide Companies
Case Studies
Classifieds
Columns
Conference Sessions
Ebook
Editorial
Executive Perspective
Expert's Opinion
FDA Watch
Features
Financial Analysis
Getting Results
Glossary
I Mak
India Report
Industry Events
Infographics
Jobs
Literature / Brochures
Live From Shows
Lowe Down
Managing Your Career
News Releases
Online Exclusives
Outsourcing Survey
Pharma Beat
Podcasts
Posters
Preclinical Outsourcing
Product Releases
Salary Survey
Services
Slideshows
Sponsored Content
Top 25 Pharma & BioPharma
Top Companies Report
Trials & Filings
Videos
Webinars
White Papers / Tech Papers
Bio News
|
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
|
Industry News
|
R&D
Merck KGaA, GSK Ink $4.2B Immunotherapy Deal
Eight immuno-oncology clinical development studies ongoing or expected to commence in 2019
Videos
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
AbbVie, Tizona in Strategic Immunotherapy Alliance
To develop and commercialize CD39-targeted therapeutics, including TTX-030, a first-in-class antibody for the treatment of cancer
01.03.19
Breaking News
|
Collaborations & Alliances
|
Drug Development
Lilly, Aduro Biotech in Immunotherapy Alliance
Will use cGAS-STING Pathway Inhibitor program to develop immunotherapies for autoimmune and other inflammatory diseases
12.19.18
Breaking News
|
Collaborations & Alliances
|
Drug Development
Amgen, Molecular Partners Enter Immunotherapy Alliance
Amgen obtains exclusive global development and commercial rights for MP0310
12.19.18
Breaking News
|
Collaborations & Alliances
|
Drug Development
Celgene Licenses Two Dragonfly Immunotherapy Candidates
The licenses represent the first two of four hematological cancer targets from the companies' June 2017 collaboration
12.13.18
Breaking News
|
Drug Development
|
Drug Discovery
|
Industry News
Celgene, Dragonfly Expand Immunotherapy Alliance
Celgene has the option to license exclusive rights to products using Dragonfly's TriNKET platform for four new targets
11.14.18
Bio News
|
Breaking News
|
Collaborations & Alliances
|
Industry News
|
Information Technology
|
R&D
Ultimovacs Acquires Immuneed's Immunotherapy Unit
The NOK 50.4mm deal includes a rename of the business unit to Ultimovacs AB
08.30.18
Bio News
|
Breaking News
|
Drug Development
|
Drug Discovery
|
Facilities
|
Industry News
|
Laboratory Testing
|
R&D
PolyU, Axis Therapeutics Partner for Immunotherapy
The joint immunotherapy center will aim to conduct collaborative research on cancer immunotherapy in Hong Kong
Videos
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
IsoPlexis, Nektar Therapeutics in Immunotherapy Alliance
Will employ IsoCode Chip's single-cell functional profiling in collaboration with Nektar to profile effects of NKTR-214
06.26.18
Clinical Trials
|
Drug Development
Rethinking Immunotherapy Clinical Endpoints in Oncology Studies
Chris Smyth and Joy Yucaitis of Novella Clinical evaluate criteria, regulations, and limitations
Chris Smyth, Ph.D. and Joy Yucaitis, Novella Clinical
10.28.16
Breaking News
SK, Arvelle Sign $530M Deal for Antiepileptic Drug
GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers
Progenics Launches Mfg. Ops in NJ
Charles River to Pay $510M for Citoxlab
West, Swissfillon Enter Drug Delivery Partnership
View Breaking News >
CURRENT ISSUE
January/February 2019
DCAT Week ’19
Temperature-Controlled Logistics
Reducing Pill Burden
Nasal Drug Delivery
AI in Pharma: Transforming Data into Drugs
Digitization: Pharma 4.0
Serialization Compliance: Understanding the Challenges
FDA & Data Integrity
Rising Demand for Lyophilized Products
Future Trends in the CDMO Space
View More >
https://servedbyadbutler.com/adserve/;ID=175026;size=1x1;type=tpixel;setID=347124;plid=886098;BID=519664169;wt=0;rnd=CACHE_BUSTER_MACRO